---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000869453.md"
description: "I think $Vistra(VST.US) looks compelling here.At $138, Vistra feels like one of the cleaner ways to play the AI/data center power trade without paying a large multiple.The numbers:- Q2 adjusted EBITDA: $1.77B, +31% YoY- 2026 EBITDA guide: $6.8B-$7.6B- 2026 FCF before growth: $3.9B-$4.7B- 2027 core EBITDA opportunity: $7.4B-$7.8B- Shares outstanding down ~30% since 2021The obvious bottleneck continues to be energy and it seems like $Vistra(VST.US) is attacking that head on: - AWS signed a 20-year deal for up to 1.2 GW from Comanche Peak.- Meta signed 20-year agreements covering 2.6+ GW across Vistra’s nuclear fleet.Roughly 3.8 GW tied to AWS + Meta alone. Then there is also Helix, the AI infrastructure platform with KKR, NVIDIA and KIA. Vistra is the preferred power provider for this. VST is also acquiring Cogentrix, adding ~5.5 GW of gas generation, with the deal expected to be accretive to FCF/share starting in 2027.The valuation is compelling:At $138:~13-15x forward EPS~9-10x 2026 EV/EBITDA~8x 2027 EV/EBITDA~10-11x 2026 FCF before growthMeanwhile $Constellation Energy(CEG.US) trades closer to ~22x forward earnings and ~14-15x EV/EBITDA.I don’t think VST deserves CEG’s full multiple, but the gap looks wide given how much exposure VST has to the same nuclear/power scarcity theme. At the same time, CEG has almost the same amount of debt as VST at $19B. CEG has much more hyperscaler exposure so it deserves a higher premium, but it seems likely for VST to be rerated on solid execution.The risks:- Merchant power prices can weaken- Debt/leverage is meaningful- Nuclear outages/regulatory issues can hurt earnings- AI power demand is already a crowded theme- Heavy hedging limits near-term upside from higher spot power prices- Cogentrix/Helix still need to execute- More generation or slower AI capex could reduce the scarcity premiumThe risks are important here but they are mainly tied to regulation/execution, the underlying thesis is that energy continues to be a huge bottleneck. What I also like is that you don’t need some crazy AI multiple for this to work and deliver returns from here as the stock is already down 15% YTD:- Bear: $1107x EBITDA / ~$7B EBITDA- Base: $1859x EBITDA / ~$8B+ EBITDA- Bull: $24010-11x EBITDA / ~$9B EBITDA$Vistra(VST.US) has $1.22B remaining on its buyback authorization and 336M shares outstanding, after repurchasing $778M of stock in 2026 and $6.5B since November 2021, helping reduce its share count by roughly 30% since 2021. That’s actually interesting now because the stock is around $138 so if management keeps allocating FCF to repurchases at these lower prices, every $1B of buybacks would retire roughly 7.2M shares, or a little over 2% of the current share count.Finally, Peter Thiel bought $59M of it in Q2 and David Tepper added to his position by 10% making it now worth 4% of his portfolio with a $350M position size. I took a small starter position today to keep track of it as  I'm still doing DD but it does feel more compelling than not.Source: amit"
datetime: "2026-08-25T19:36:52.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000869453.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000869453.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000869453.md)
author: "[amit](https://longbridge.com/en/profiles/24261296.md)"
generator: "portal-rs"
---

# I think $Vistra(VST.US) looks compelling here.At $…


### Related Stocks

- [VST.US](https://longbridge.com/en/quote/VST.US.md)
- [AMZN.US](https://longbridge.com/en/quote/AMZN.US.md)
- [META.US](https://longbridge.com/en/quote/META.US.md)
- [KKR.US](https://longbridge.com/en/quote/KKR.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [KKR-D.US](https://longbridge.com/en/quote/KKR-D.US.md)
- [KKRT.US](https://longbridge.com/en/quote/KKRT.US.md)
- [CEG.US](https://longbridge.com/en/quote/CEG.US.md)
- [KKRS.US](https://longbridge.com/en/quote/KKRS.US.md)
- [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**